IVP · As filed with the SEC
Inspire Veterinary Partners balance sheet, by fiscal year
The statement as Inspire Veterinary Partners presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD
| USD | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 |
|---|---|---|---|
| Assets | |||
| Current assets: | |||
| Cash and cash equivalents | 523,690 | 178,961 | 444,253 |
| Accounts receivable, net | 40,675 | 28,573 | — |
| Due from former owners | — | 32,519 | 269,883 |
| Inventory | 516,650 | 571,512 | 582,019 |
| Refundable income tax | — | 151,796 | 192,139 |
| Prepaid expenses and other current assets | 942,456 | 388,759 | 253,795 |
| Total current assets | 2,023,471 | 1,352,120 | 1,742,089 |
| Restricted cash - non-current | 200,000 | 200,000 | — |
| Property and equipment, net | 6,382,788 | 7,949,144 | 7,323,050 |
| Right-of-use assets | 1,879,729 | 1,616,198 | 746,973 |
| Other intangibles, net | 1,633,927 | 2,513,028 | 2,729,574 |
| Goodwill | 8,022,082 | 8,147,590 | 7,614,553 |
| Other assets | 53,997 | 12,895 | 29,456 |
| Total assets | 20,195,994 | 21,790,975 | 20,185,695 |
| Liabilities and Stockholder’s Deficit | |||
| Current liabilities: | |||
| Accounts payable | 1,979,503 | 3,206,594 | 1,018,931 |
| Accrued expenses | 285,770 | 858,334 | 690,740 |
| Cumulative Series A preferred stock dividends payable | — | 92,322 | — |
| Operating lease liabilities | 183,981 | 141,691 | 91,152 |
| Loan payable, net of discount | — | 1,713,831 | — |
| Bridge note, net of discount | — | — | 3,899,156 |
| Loans payable, net of discount | 2,340,020 | — | — |
| Convertible debentures, net of issuance costs | — | 100,000 | — |
| Notes payable, net of discount | — | 1,469,043 | 1,549,861 |
| Notes payable, net of discount | 3,410,465 | — | — |
| Total current liabilities | 8,199,739 | 7,581,815 | 7,249,840 |
| Operating lease liabilities, non-current | 1,943,487 | 1,514,044 | 666,179 |
| Convertible debentures, net of issuance costs | — | — | 3,688,805 |
| Notes payable - noncurrent | 8,490,763 | 13,483,375 | 13,716,352 |
| Total liabilities | 18,633,989 | 22,579,234 | 25,321,176 |
| Stockholder’s Equity (Deficit) | |||
| Class A | 117 | 705 | 98 |
| Class B | 302 | 389 | 430 |
| Convertible Series A | — | 40 | — |
| Additional paid in capital | 37,911,867 | 20,425,864 | 1,107,439 |
| Accumulated deficit | (36,350,281) | (21,215,257) | (6,243,448) |
| Total stockholder’s equity (deficit) | 1,562,005 | (788,259) | (5,135,481) |
| Total liabilities and stockholder’s equity (deficit) | 20,195,994 | 21,790,975 | 20,185,695 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.